Compare FMC Corp (FMC) vs Charles Schwab Corporation Common Stock (SCHW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs Charles Schwab Corporation Common Stock — how do they compare? FMC Corp trades at $11.16 (market cap $1.36B), while Charles Schwab Corporation Common Stock trades at $102.98 (market cap $178.77B). The key difference: Charles Schwab Corporation Common Stock is far larger — about 131.4× FMC Corp's market cap, and FMC Corp pays the higher dividend (2.95%). Which is the better fit depends on your goals.
| FMC | SCHW | |
|---|---|---|
Market Cap | $1.36B | $178.77B |
Sector | Basic Materials | Financials |
52-Week High | $43.90 | $107.21 |
52-Week Low | $10.72 | $85.35 |
Enterprise Value | $5.50B | — |
Dividend Yield | 2.95% | 1.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $10.72, down 1.74% on the day, reflecting ongoing challenges despite recent strategic moves. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal significant pressure with a net income margin of -72.93% and negative ROE of -80.78% for 2025. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide rimisoxafen, providing some operational support amid financial restructuring.
The outlook remains cautious with analyst consensus leaning neutral (50% Hold) despite a $16 price target suggesting 49% upside. Key risks include persistent revenue declines, high debt levels, and negative cash flow from operations. Investment opportunity exists if new product approvals and debt reduction efforts successfully stabilize profitability, but current financial metrics indicate substantial execution risk near term.
Charles Schwab (SCHW) trades at $101.10, down 1.25% today, but maintains strong fundamental momentum with three consecutive quarterly earnings beats. The stock shows bullish technical signals with moving averages supporting upward momentum, though RSI levels suggest potential near-term overbought conditions. Recent financial performance demonstrates robust revenue growth to $23.92 billion in 2025 and net income margin expansion to 37.99%, supported by strong trading activity and asset management fees.
The outlook remains positive with analyst consensus pointing to 25.9% upside potential to $123.71. Key catalysts include continued earnings growth and strong retail trading activity, while risks involve interest rate sensitivity and market volatility. With 58% of analysts maintaining buy ratings and improving cash flow trends, SCHW presents a compelling investment case for growth-oriented investors despite current valuation multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About Charles Schwab Corporation Common Stock
Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.
Read more on SCHW →
